Page last updated: 2024-08-23

etoposide and Diathesis

etoposide has been researched along with Diathesis in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (20.00)	18.7374
1990's	4 (80.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Blackwell, S; Buchanan, M; Clark, RE; Crawford, J; Grichnik, JM; Hitchcock, MG; Jimenez, F; Kurtzberg, J	1
Fields, LL; Maziarz, RT; White, CR	1
Dann, EJ; Gillis, S; Rund, D	1
Bairey, O; Blickstein, D; Hadar, H; Lahav, M; Prokocimer, M; Shaklai, M; Shaklai, S; Sulkes, J	1
Kaplan, LD; Volberding, PA	1

Reviews

1 review(s) available for etoposide and Diathesis

Article	Year
Treatment of AIDS and its attendant malignancies. Progress in clinical and biological research, 1989, Volume: 288 Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Anemia; Antineoplastic Combined Chemotherapy Protocols; Disease Susceptibility; Doxorubicin; Etoposide; Humans; Lymphoma, Non-Hodgkin; Neutropenia; Sarcoma, Kaposi; Vinblastine; Vincristine; Zidovudine	1989

Trials

2 trial(s) available for etoposide and Diathesis

Article	Year
Human recombinant stem-cell factor induces melanocytic hyperplasia in susceptible patients. Journal of the American Academy of Dermatology, 1995, Volume: 33, Issue:4 Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cell Adhesion Molecules; Dendrites; Disease Susceptibility; Etoposide; Follow-Up Studies; Hematopoietic Cell Growth Factors; Humans; Hyperpigmentation; Hyperplasia; Injections, Subcutaneous; Lung Neoplasms; Melanins; Melanocytes; Recombinant Proteins; Stem Cell Factor	1995
Severe myelotoxicity of oral etoposide in heavily pretreated patients with non-Hodgkin's lymphoma or chronic lymphatic leukemia. Cancer, 1996, Jun-01, Volume: 77, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Disease Progression; Disease Susceptibility; Etoposide; Female; Gastrointestinal Diseases; Humans; Infections; Leukemia, Lymphocytic, Chronic, B-Cell; Leukocyte Count; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Prednisone; Remission Induction; Salvage Therapy	1996

Article

Year

Human recombinant stem-cell factor induces melanocytic hyperplasia in susceptible patients.

Journal of the American Academy of Dermatology, 1995, Volume: 33, Issue:4

Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cell Adhesion Molecules; Dendrites; Disease Susceptibility; Etoposide; Follow-Up Studies; Hematopoietic Cell Growth Factors; Humans; Hyperpigmentation; Hyperplasia; Injections, Subcutaneous; Lung Neoplasms; Melanins; Melanocytes; Recombinant Proteins; Stem Cell Factor

1995

Severe myelotoxicity of oral etoposide in heavily pretreated patients with non-Hodgkin's lymphoma or chronic lymphatic leukemia.

Cancer, 1996, Jun-01, Volume: 77, Issue:11

Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Disease Progression; Disease Susceptibility; Etoposide; Female; Gastrointestinal Diseases; Humans; Infections; Leukemia, Lymphocytic, Chronic, B-Cell; Leukocyte Count; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Prednisone; Remission Induction; Salvage Therapy

1996

Other Studies

2 other study(ies) available for etoposide and Diathesis

Article	Year
Rapid development of disseminated superficial porokeratosis after transplant induction therapy. Bone marrow transplantation, 1995, Volume: 15, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Disease Susceptibility; Doxorubicin; Etoposide; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Porokeratosis; Prednisone; Skin; Vincristine; Whole-Body Irradiation	1995
Selective discharge of patients with acute myeloid leukemia during chemotherapy-induced neutropenia. American journal of hematology, 1996, Volume: 51, Issue:1 Topics: Acute Disease; Adult; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Catheterization, Central Venous; Cross Infection; Cytarabine; Daunorubicin; Disease Susceptibility; Etoposide; Female; Fever; Humans; Leukemia, Myeloid; Male; Middle Aged; Mitoxantrone; Neutropenia; Patient Discharge; Safety; Treatment Outcome	1996

Article

Year

Rapid development of disseminated superficial porokeratosis after transplant induction therapy.

Bone marrow transplantation, 1995, Volume: 15, Issue:6

Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Disease Susceptibility; Doxorubicin; Etoposide; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Porokeratosis; Prednisone; Skin; Vincristine; Whole-Body Irradiation

1995

Selective discharge of patients with acute myeloid leukemia during chemotherapy-induced neutropenia.

American journal of hematology, 1996, Volume: 51, Issue:1

Topics: Acute Disease; Adult; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Catheterization, Central Venous; Cross Infection; Cytarabine; Daunorubicin; Disease Susceptibility; Etoposide; Female; Fever; Humans; Leukemia, Myeloid; Male; Middle Aged; Mitoxantrone; Neutropenia; Patient Discharge; Safety; Treatment Outcome

1996